Learning Objectives:
1. To appreciate the relationship between obesity-related metabolic changes and risk for CKD
2. To be aware of the numerous described pathophysiologic pathways of obsesity-related CVD and CKD
3. To be aware of newer more specific targeted therapies in improving clinical outcomes in people with
Session date:
09/12/2024 - 4:00pm to 5:00pm CDT
Location:
Via Zoom
5841 S. Maryland Ave
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Matthew R. Weir, MD